Latest Board Appointment News

Yari Minerals has significantly expanded its flagship Rolleston South Coal Project resource by 91%, positioning itself strongly in Queensland’s Bowen Basin ahead of a maiden drilling campaign planned for late 2025.

Astute Metals NL sharpens its focus on Nevada’s rich mineral landscape, unveiling fresh high-grade gold targets at Needles and reaffirming lithium potential at Red Mountain amid leadership changes.

American Rare Earths announces the resignation of CEO Chris Gibbs as leadership transitions to focus on advancing the Halleck Creek Project, with minimal disruption expected.

Openn Negotiation Ltd reported a significantly reduced net loss of $3.93 million for FY24, exiting voluntary administration with new directors and a recapitalisation led by ST Holding 2 Pty Ltd. The company faces challenges in regaining ASX compliance and identifying new business operations.

Openn Negotiation Ltd remains under a Deed of Company Arrangement with no operational activity during the September quarter, focusing on recapitalisation efforts following insolvency and voluntary administration.

Solstice Minerals reports robust drilling results at its Yarri Gold Project and identifies significant resource extension targets at Nanadie Copper-Gold Project, supported by a $2.1 million strategic placement and a key board appointment.

Broken Hill Mines Limited has completed its acquisition of Broken Hill Mines Holdings Pty Ltd, restructured its board, and is preparing for a trading reinstatement on the ASX under the ticker 'BHM'.

Pacific Edge reports steady demand for its Cxbladder cancer diagnostic tests despite losing Medicare coverage and transitioning US customers to a new test. The company is advancing clinical evidence and a $21 million capital raise to support growth and regain coverage.

Netwealth Group Limited has reported a record $15.8 billion in Funds Under Administration net flows for FY25, marking a 40% increase over the previous year and pushing total FUA to $112.8 billion. The company’s strong platform growth and strategic board appointment signal continued momentum.

ClearVue Technologies announces key leadership changes with COO Douglas Hunt stepping in as interim CEO, alongside two new board appointments, signaling a strategic push to accelerate growth and innovation.

NeuroScientific Biopharmaceuticals has completed its acquisition of StemSmart stem cell technology, setting the stage for a focused clinical push in treating fistulising Crohn’s disease. The company also refreshed its board and raised $7.5 million to support this next phase.

White Cliff Minerals appoints mining veteran John Hancock to its board and engages Astrotricha Capital as advisors, setting the stage for a major drilling campaign at the Rae Copper Project.